Home › Idiopathic Hypersomnia › New Jersey
Idiopathic Hypersomnia clinical trials in New Jersey
3 studies for Idiopathic Hypersomnia are looking for participants at sites in New Jersey.
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Patient First MD, Middletown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07500090A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Takeda Site 19, Middletown
RecruitingPhase 2/3
Ages 18 to 71 · All sexes · Updated Nov 5, 2026 · NCT07646678A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Middletown
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Oct 9, 2026 · NCT06767683From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.